Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Warrick

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Human Pathology|June 19, 2012
Mucinous breast carcinomas lack PIK3CA and AKT1 mutationsElizabeth L Kehr, Julie M Jorns, Daphne Ang, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 14, 2015
Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targetsDaphne Ang, Morgan Ballard, Carol Beadling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2009
High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breastMegan L Troxell, Judith Levine, Carol Beadling, et al.
Sarcoma|June 15, 2013
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing RhabdomyosarcomaKen Kikuchi, George R Wettach, Christopher W Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancerChristine M Barnett, Michael C Heinrich, Jeong Lim, et al.
Human Pathology|June 5, 2012
Multiplex high-throughput gene mutation analysis in acute myeloid leukemiaJennifer Dunlap, Carol Beadling, Andrea Warrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
KIT gene mutations and copy number in melanoma subtypesCarol Beadling, Erick Jacobson-Dunlop, F Stephen Hodi, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project"Peter H O'Donnell, Keith Danahey, Michael Jacobs, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registryCarol Beadling, Michael C Heinrich, Andrea Warrick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trialAriel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Human Pathology|June 19, 2012
Mucinous breast carcinomas lack PIK3CA and AKT1 mutationsElizabeth L Kehr, Julie M Jorns, Daphne Ang, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 14, 2015
Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targetsDaphne Ang, Morgan Ballard, Carol Beadling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2009
High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breastMegan L Troxell, Judith Levine, Carol Beadling, et al.
Sarcoma|June 15, 2013
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing RhabdomyosarcomaKen Kikuchi, George R Wettach, Christopher W Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancerChristine M Barnett, Michael C Heinrich, Jeong Lim, et al.
Human Pathology|June 5, 2012
Multiplex high-throughput gene mutation analysis in acute myeloid leukemiaJennifer Dunlap, Carol Beadling, Andrea Warrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
KIT gene mutations and copy number in melanoma subtypesCarol Beadling, Erick Jacobson-Dunlop, F Stephen Hodi, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project"Peter H O'Donnell, Keith Danahey, Michael Jacobs, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registryCarol Beadling, Michael C Heinrich, Andrea Warrick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trialAriel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Pageof 2